Dr. Philip Andrew Lowry, MD

Dr. Lowry practices at Parkview Bryan Hospital in Bryan, Ohio, part of Parkview Health System.

Dr. Lowry's NPI, 1518949080, was assigned on November 18, 2005. Dr. Lowry graduated from Yale School of Medicine in 1981. Dr. Lowry holds Ohio license 35.054656.

Dr. Lowry's primary practice is Parkview Bryan Hospital, at 433 West High Street, Bryan, OH 43506 in Williams County. The practice phone is (419) 636-1131.

Dr. Lowry's primary practice is Parkview Bryan Hospital in Bryan, Ohio, part of Parkview Health System. Dr. Lowry is also affiliated with Parkview Regional Medical Center. The medical group on file is Parkview Physicians Group, Midwest Community Health Associates. Dmand AI also links Dr. Lowry to 4 more hospitals, 4 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lowry practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Lowry's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Lowry's licenses on file in 3 states: Ohio, Massachusetts and Pennsylvania.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, immune deficiency disease, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Lowry treats.

CMS data shows 498 Medicare services from Dr. Lowry across 5 procedure codes in 2024, for 186 Medicare patients. Medicare paid $33,608 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 186 Medicare patients who saw Dr. Lowry in 2024. The largest group is 65 to 74, with 81 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lowry's median patient age at 73, with 50% women.

In 2024, Dr. Lowry wrote 732 Medicare Part D claims for 182 patients. 83% of them were for generic drugs. CMS names the drug for 529 of them, across 23 drugs with 11 or more claims each, at $124,920 in total drug cost. In 2023, CMS named 731 claims across 23 drugs.

Dr. Lowry accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 20 papers to Dr. Lowry, published from 2011 to 2022. The most frequent topics are Bone Marrow Transplantation, Hematopoietic Stem Cells and Bone Marrow. Dr. Lowry has published most often in Blood. Dr. Lowry's most frequent co-authors are Forrest Marc Stewart, MD, Shobha Mandal and Michael Andreeff, MD.

Dmand AI links Dr. Lowry to 10 clinical trials, 6 of them phase 3 studies. 8 are still active or recruiting. Conditions studied include Carcinoma, Non-Small-Cell Lung, Melanoma and Carcinoma, Bronchogenic. National Cancer Institute (NCI) sponsors the most, 8.

CMS Open Payments shows 3 general payments to Dr. Lowry from 2 drug and device companies from 2020 to 2022. Education make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $43.

Dmand AI lists 1 award for Dr. Lowry, most recently CMS Stage 1 EHR in 2013.

Dr. Lowry graduated from Yale School of Medicine in 1981.

Dr. Lowry is in network with 10 carriers, including Aetna, Highmark and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.